Transplantation Market 2018 Global Analysis, Opportunities, Challenges, Key Players, Scope and Forecast to 2025

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

This report focuses on the global Transplantation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transplantation development in United States, Europe and China.

Transplantation is a procedure wherein diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functioning of the body. Donor and recipient cells, tissues, and organs should match or be compatible, or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient’s immune system may not adapt to. This can lead to rejection of an organ. Hence, serological and human leukocyte antigen (HLAs) tests are conducted to help identify the antigens and help in successful organ transplantation. With HLA testing, immunosuppressive drugs are provided to minimize graft rejection. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.
M&A between small specialized hospitals and Tier-1 hospitals is one of the primary drivers for market growth. Rising acquisition of small hospitals by large tier-1 hospitals has led to the betterment of organ transplantation, wound care, and diagnosis that has indirectly impacted the growth of the transplantation market positively. These acquisitions assist in training the healthcare staff, including physicians and nurses, and patients are open to avail a range of patient monitoring equipment. Moreover, the brand name of the large hospitals attracts people to receive healthcare services that increase the requirement for transplant diagnostic products, assays, and kits. Also, M&A of small and medium-sized hospitals with large hospitals has increased the availability of services such as dedicated treatments for nephrology and cardiology, which in turn, meets the demands of patients.
The Americas led the global transplantation market during 2017 and is foreseen to continue the domination during the forecast period. Factors like unhealthy dietary habits, consumption of alcohol, and severe diseases such as ESRD and liver cirrhosis leads to incidents of organ failure thus driving the demand for transplantation in the region.
In 2017, the global Transplantation market size was 73000 million US$ and it is expected to reach 154200 million US$ by the end of 2025, with a CAGR of 9.8% during 2018-2025.

Request a Sample Report @

The key players covered in this study
Zimmer Biomet
Teva Pharmaceuticals
Veloxis Pharmaceuticals

Market segment by Type, the product can be split into
Kidney Transplantation
Liver Transplantation
Heart Transplantation
Lung Transplantation
Pancreas Transplantation

Market segment by Application, split into
Hospitals and Transplant Centers
Diagnostic Registries and Research Laboratories

Market segment by Regions/Countries, this report covers
United States
Southeast Asia
Central & South America

The study objectives of this report are:
To analyze global Transplantation status, future forecast, growth opportunity, key market and key players.
To present the Transplantation development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Transplantation Market Size Growth Rate by Type (2013-2025)
1.4.2 Kidney Transplantation
1.4.3 Liver Transplantation
1.4.4 Heart Transplantation
1.4.5 Lung Transplantation
1.4.6 Pancreas Transplantation
1.5 Market by Application
1.5.1 Global Transplantation Market Share by Application (2013-2025)
1.5.2 Hospitals and Transplant Centers
1.5.3 Diagnostic Registries and Research Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Transplantation Market Size
2.2 Transplantation Growth Trends by Regions
2.2.1 Transplantation Market Size by Regions (2013-2025)
2.2.2 Transplantation Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Transplantation Market Size by Manufacturers
3.1.1 Global Transplantation Revenue by Manufacturers (2013-2018)
3.1.2 Global Transplantation Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Transplantation Market Concentration Ratio (CR5 and HHI)
3.2 Transplantation Key Players Head office and Area Served
3.3 Key Players Transplantation Product/Solution/Service
3.4 Date of Enter into Transplantation Market
3.5 Mergers & Acquisitions, Expansion Plans


12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Transplantation Introduction
12.1.4 AbbVie Revenue in Transplantation Business (2013-2018)
12.1.5 AbbVie Recent Development
12.2 Arthrex
12.2.1 Arthrex Company Details
12.2.2 Company Description and Business Overview
12.2.3 Transplantation Introduction
12.2.4 Arthrex Revenue in Transplantation Business (2013-2018)
12.2.5 Arthrex Recent Development
12.3 Zimmer Biomet
12.3.1 Zimmer Biomet Company Details
12.3.2 Company Description and Business Overview
12.3.3 Transplantation Introduction
12.3.4 Zimmer Biomet Revenue in Transplantation Business (2013-2018)
12.3.5 Zimmer Biomet Recent Development
12.4 Medtronic
12.4.1 Medtronic Company Details
12.4.2 Company Description and Business Overview
12.4.3 Transplantation Introduction
12.4.4 Medtronic Revenue in Transplantation Business (2013-2018)
12.4.5 Medtronic Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Transplantation Introduction
12.5.4 Novartis Revenue in Transplantation Business (2013-2018)
12.5.5 Novartis Recent Development
12.6 Stryker
12.6.1 Stryker Company Details
12.6.2 Company Description and Business Overview
12.6.3 Transplantation Introduction
12.6.4 Stryker Revenue in Transplantation Business (2013-2018)
12.6.5 Stryker Recent Development
12.7 BioLifeSolutions
12.7.1 BioLifeSolutions Company Details
12.7.2 Company Description and Business Overview
12.7.3 Transplantation Introduction
12.7.4 BioLifeSolutions Revenue in Transplantation Business (2013-2018)
12.7.5 BioLifeSolutions Recent Development
12.8 Teva Pharmaceuticals
12.8.1 Teva Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Transplantation Introduction
12.8.4 Teva Pharmaceuticals Revenue in Transplantation Business (2013-2018)
12.8.5 Teva Pharmaceuticals Recent Development
12.9 Veloxis Pharmaceuticals
12.9.1 Veloxis Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Transplantation Introduction
12.9.4 Veloxis Pharmaceuticals Revenue in Transplantation Business (2013-2018)
12.9.5 Veloxis Pharmaceuticals Recent Development


Access Complete Report @

Media Contact
Company Name:
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India